Multiple Sclerosis and Pregnancy: Current Considerations

被引:23
作者
Buraga, Ioan [1 ]
Popovici, Roxana-Elena [2 ]
机构
[1] Carol Davila Univ Med & Pharm, Colentina Clin Hosp, Bucharest 020125, Romania
[2] Colentina Clin Hosp, Dept Neurol, Bucharest 020125, Romania
关键词
GLATIRAMER ACETATE; INTERFERON-BETA; FETAL OUTCOMES; EXPOSURE; RISK; MULTICENTER; NATALIZUMAB; MANAGEMENT; THERAPY; RELAPSE;
D O I
10.1155/2014/513160
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Multiple sclerosis is the most common neurological disease of young adults that causes major disability. In Romania, it is estimated that this disease has a prevalence of 35-40 per 100,000 inhabitants. It is a disease that begins at the age of 20-40 years and is 2-3 times more common in women than in men. More than half of patients with MS develop the disease in their fertile period of life; therefore, MS patients use contraceptive methods while being under our treatment. Since several therapeutic options have been implemented with good efficiency in the disease stabilization, increasingly more patients begin to wonder about the possibility of having a child and about the possible risks of pregnancy. The evolution during pregnancy and the lactation period has been favorable, with lower relapses and side effects comparable to those in the general population. In addition, babies born to mothers with MS have not had a significantly different mean gestational age or birth weight compared to babies born to healthy mothers.
引用
收藏
页数:6
相关论文
共 47 条
[1]   Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis [J].
Achiron, A ;
Kishner, I ;
Dolev, M ;
Stern, Y ;
Dulitzky, M ;
Schiff, E ;
Achiron, R .
JOURNAL OF NEUROLOGY, 2004, 251 (09) :1133-1137
[2]   Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis [J].
Amato, M. P. ;
Portaccio, E. ;
Ghezzi, A. ;
Hakiki, B. ;
Zipoli, V. ;
Martinelli, V. ;
Moiola, L. ;
Patti, F. ;
La Mantia, L. ;
Mancardi, G. L. ;
Solaro, C. ;
Tola, M. R. ;
Pozzilli, C. ;
De Giglio, L. ;
Totaro, R. ;
Lugaresi, A. ;
Di Tommaso, V. ;
Paolicelli, D. ;
Marrosu, M. G. ;
Comi, G. ;
Pellegrini, F. ;
Trojano, M. .
NEUROLOGY, 2010, 75 (20) :1794-1802
[3]  
[Anonymous], 2012, TYS NAT PRESCR INF
[4]  
Bjork A, 2002, Patent, Patent No. 6593343
[5]   The reproductive effects of beta interferon therapy in pregnancy - A longitudinal cohort [J].
Boskovic, R ;
Wide, R ;
Wolpin, J ;
Bauer, DJ ;
Koren, G .
NEUROLOGY, 2005, 65 (06) :807-811
[6]  
Briggs G.G., 2011, Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk
[7]  
Collins W., 2011, P 63 ANN M AM AC NEU
[8]   European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis [J].
Comi, G ;
Filippi, M ;
Wolinsky, JS .
ANNALS OF NEUROLOGY, 2001, 49 (03) :290-297
[9]   Rate of pregnancy-related relapse in multiple sclerosis [J].
Confavreux, C ;
Hutchinson, M ;
Hours, MM ;
Cortinovis-Tourniaire, P ;
Moreau, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (05) :285-291
[10]  
Coyle P. K., FINAL RESULTS BETASE